Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review. [PDF]
Fu AZ +5 more
europepmc +1 more source
In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. [PDF]
Parab MM +7 more
europepmc +1 more source
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin. [PDF]
Levomäki R +3 more
europepmc +1 more source
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity. [PDF]
Zacharias NM +54 more
europepmc +1 more source
Lapatinib suppresses cysteine deprivation-induced ferroptotic cell death by modulating mitochondrial function. [PDF]
Kim G +6 more
europepmc +1 more source
Case Report: Fatal pneumonitis caused by Camrelizumab and Erlotinib in a patient with metastatic pancreatic cancer. [PDF]
Jiang Y, Ma L, Lu B, Tian W.
europepmc +1 more source
Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. [PDF]
Hulskotte LMG +8 more
europepmc +1 more source
Liv-52 Attenuates Erlotinib-Induced Liver Injury via Modulation of Oxidative Stress, Inflammation, and Apoptosis in Rats. [PDF]
Bulut S +8 more
europepmc +1 more source
Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer. [PDF]
Raninga PV +7 more
europepmc +1 more source
Effects of Benzo[a]pyrene on Targeted Therapy Response and Platelet-Activating Factor-Receptor-Mediated Microvesicle Particle Release in Non-Small Cell Lung Cancer. [PDF]
Rawal R, Thyagarajan A, Sahu RP.
europepmc +1 more source

